{
  "docId": "019dd923-622c-750b-8b96-76efb5813bae",
  "docSlug": "8ff52fe302da",
  "documentTitle": "St. Jude Medical (STJ)",
  "authorId": "51_Muddy_Waters",
  "authorName": "Carson C. Block",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2016-08-25 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 29,
  "pageCount": 34,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "scenario_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 264,
  "notes": "The tables represent a sensitivity analysis for St. Jude Medical (STJ) based on a hypothetical market share loss scenario.",
  "elementsJson": [
    "valuation_table",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b96-76efb5813bae/29",
  "deckHref": "/decks/019dd923-622c-750b-8b96-76efb5813bae",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b96-76efb5813bae.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b96-76efb5813bae#slide-29",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "In this scenario, the company loses market share and revenue, but continues to operate its Traditional CRM and Heart Failure segment.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-1ac3-70f9-8550-ac26eb0eba75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.75,
        "x": 0.14,
        "y": 0.51
      },
      "kind": "list",
      "text": "Narrative explanation of the share loss scenario and historical precedent (Thoratec)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "763fc556-9d1c-4e75-a9fc-de4ae0825ec1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "STJ Share Price Change: -87%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-1ac3-70f9-8550-b00b35650fb9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.117,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "Footnotes regarding Thoratec market share loss and STJ share price reference",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1ef4c3b-a8da-4472-83ac-f702fc689b46",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.75,
        "x": 0.16,
        "y": 0.09
      },
      "kind": "table",
      "text": "Sensitivity tables for Enterprise Value, EV/EBITDA, Share Price, and Share Price Change",
      "attrs": null,
      "subkind": "valuation",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89813868-29df-4b08-acf0-b82059bfca80",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.117,
        "y": 0.48
      },
      "kind": "title",
      "text": "Share Loss and Revenue Loss Scenario:",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b2d4d97-e674-445c-b5bb-5b008503323b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "sensitivity-analysis",
      "slug": null,
      "matchId": "e32893f8-e868-4d48-8a8b-42a7ebbf098a",
      "evidence": "Tables showing impact of varying WACC and growth assumptions",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 30,
      "from": 25,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ab9a2b66-8b1d-4abd-96ba-1ffd9bf1975e",
      "evidence": "The document presents a scenario table analyzing Boston Scientific's revenue drop after recalls",
      "position": 0,
      "objective": "What are the financial implications of inaction on device recalls?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}